NII Aisuke | Drug Safety Research and Development ; Global Research and Development, Nagoya Laboratories, Pfizer
スポンサーリンク
概要
- 同名の論文著者
- Drug Safety Research and Development ; Global Research and Development, Nagoya Laboratories, Pfizer の論文著者
関連著者
-
NII Aisuke
Drug Safety Research and Development ; Global Research and Development, Nagoya Laboratories, Pfizer
-
Nii Aisuke
Drug Safety Research & Development Nagoya Laboratories Pfizer Global Research And Development
-
SHIRAI NORIMITSU
Drug Safety Evaluation, Nagoya Laboratories, Pfizer Global Research and Development
-
IIDAKA TAKESHI
Drug Safety Evaluation, Nagoya Laboratories, Pfizer Global Research and Development
-
HORII IKUO
Drug Safety Evaluation, Nagoya Laboratories, Pfizer Global Research and Development
-
Iidaka Takeshi
ファイザー 中央研究所
-
Iidaka Takeshi
Drug Safety Research And Development Pfizer Global Research And Development Nagoya Laboratories. Pfi
-
Iidaka Takeshi
ファイザー製薬中央研究所 安全性研究統括部
-
Iidaka Takeshi
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Iidaka Takeshi
ファイザー製薬中央研究所 安全性研究
-
Ohmi Takashi
Discovery Biology Research Nagoya Laboratories Pfizer Japan Inc.
-
SATO Yasushi
Drug Safety Research & Development, Pfizer Global Research & Development, Nagoya Laboratories
-
Kurata Masaaki
ファイザー製薬中央研究所 安全性研究統括部
-
Kurata Masaaki
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
KOJIMA Midori
Discovery Biology Research, Nagoya Laboratories, Pfizer Japan Inc.
-
KATO Naoto
Discovery Biology Research, Nagoya Laboratories, Pfizer Japan Inc.
-
HIRANO Daisuke
Discovery Biology Research, Nagoya Laboratories, Pfizer Japan Inc.
-
OCHI Takashi
Discovery Biology Research, Nagoya Laboratories, Pfizer Japan Inc.
-
SHINJO Katsuhiro
Discovery Biology Research, Nagoya Laboratories, Pfizer Japan Inc.
-
EDA Hiroyuki
Discovery Biology Research, Nagoya Laboratories, Pfizer Japan Inc.
-
TASHIRO Toshifumi
Drug Safety Research and Development, Nagoya Laboratories, Pfizer Global Research and Development, P
-
NAGAKUI Yuko
Drug Safety Research and Development, Nagoya Laboratories, Pfizer Global Research and Development, P
-
NAKAMURA Takaaki
Drug Safety Research and Development, Nagoya Laboratories, Pfizer Global Research and Development, P
-
Hirano Daisuke
Discovery Biology Research Nagoya Laboratories Pfizer Japan Inc.
-
Nagakui Yuko
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Tashiro Toshifumi
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Shinjo Katsuhiro
Discovery Biology Research Nagoya Laboratories Pfizer Japan Inc.
-
Nakamura Takaaki
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Kato Naoto
Discovery Biology Research Nagoya Laboratories Pfizer Japan Inc.
-
Nii Aisuke
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Nii Aisuke
Drug Safety Research And Development ; Global Research And Development Nagoya Laboratories Pfizer Ja
-
Eda Hiroyuki
Discovery Biology Research Nagoya Laboratories Pfizer Japan Inc.
-
Eda Hiroyuki
Discovery Biology Research Global Research & Development Nagoya Laboratories Pfizer Japan Inc.
-
Kojima Midori
Discovery Biology Research Nagoya Laboratories Pfizer Japan Inc.
-
Ochi Takashi
Discovery Biology Nagoya Laboratories Pfizer Global Research And Development
-
Sato Yasushi
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Kurata Masaaki
Drug Safety Research And Development Nagoya Laboratories Pfizer Global Research And Development Pfiz
-
Sato Yasushi
Drug Safety And Pharmacokinetics Laboratories Taisho Pharmaceutical Co. Ltd.
-
Tashiro Toshifumi
Drug Safety & Disposition Research Laboratories, Eisai Co., Ltd.
著作論文
- Selective CB1 cannabinoid receptor antagonist, SR141716A, attenuates liver injury induced by Concanavalin A
- Erythroderma and Epidermal Necrosis Induced by a Type of Proton Pump Inhibitor in Beagle Dogs
- Neuronal Necrosis in a Dog Following Exposure to an NMDA Receptor Antagonist